Cancer BiologybioRxivPreprint
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma
E. Aliagas, A. Alay, M. Martinez-Iniesta…·E. Nadal
This study evaluates CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma, finding they reduce tumor growth and improve survival by inducing cell cycle arrest and senescence.
DOI 10.1101/2021.02.08.430196